Cell Bio-Systems CEO Speaks to WallStreetReporter.Business Editors/High-Tech Writers SAN DIEGO, Calif.--(BUSINESS WIRE)--June 10, 2004 Cell Bio-Systems, Inc. (Pink Sheets: CBSI CBSI CUNA Brokerage Services, Inc. CBSI Cambodian Buddhist Society, Inc. (Silver Springs, Maryland) CBSI Certified Bridge Safety Inspector CBSI Custom Business Solutions, Inc. ), a biotechnology company seeking to manufacture and distribute patented, disposable technologies for cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. and other living tissue procedures, announced today that its president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Marc Pilkington, has been interviewed as a featured guest on WallStreetReporter.com, a leading financial news and information portal. Visitors to the site and interested investors are encouraged to listen to streamed audio of the interview at: http://www.wallstreetreporter.com/profiles/CellBioSystems.html. Pilkington described his company's near-term market potential in plastic and orthopedic surgery Orthopedic Surgery Definition Orthopedic (sometimes spelled orthopaedic) surgery is surgery performed by a medical specialist, such as an orthopedist or orthopedic surgeon, trained to deal with problems that develop in the bones, joints, and ligaments , and the adaptability of Cell Bio-Systems products for protein or gene therapy and other areas in the long term. He also discussed his company's strategies to streamline time to market by outsourcing manufacturing, managing domestic distribution internally, and negotiating for distribution abroad. "Cell Bio-Systems' line of patented, disposable products was extremely well-received last year at the annual meeting of the American Society of Plastic Surgeons The American Society of Plastic Surgeons (ASPS) is the largest plastic surgery specialty organization in the world. Founded in 1931, the society is composed of surgeons certified by the American Board of Plastic Surgery or or by the Royal College of Physicians and Surgeons of , and we have a number of top surgeons already onboard to help develop and test them," said Pilkington. "Rarely do investors have the opportunity to invest for financial potential as well as for a cause that will benefit humanity. With an investment in CBSI, investors have the opportunity to do both." About Cell Bio-Systems Based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction Liposuction Definition Liposuction, also known as lipoplasty or suction-assisted lipectomy, is cosmetic surgery performed to remove unwanted deposits of fat from under the skin. and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product line that will fill this void in the cosmetic surgery and living tissue marketplace. The company's patented, groundbreaking technology will increase patient safety and enhance procedural outcomes. Most notably, Cell Bio-Systems devices can be adapted for a variety of procedures, ranging from fat transfers to biopsies to stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research. The company ultimately will develop a complete living tissue management system. CBSI shareholders are encouraged to visit www.cellbiosystems.com and to register on the "Investor Relations Investor relations The process by which the corporation communicates with its investors. " page to receive ongoing CBSI news updates. Legal Notice Regarding Forward-Looking Statements: "Forward-looking statements'' as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. CBSI disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions (including in the information technology and financial information industry), actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion